Efficacy of SXN in the Treatment of Iron Deficiency Anemia: A Phase IV Clinical Trial
Table 5
Adverse events (AEs).
Adverse event
Total number of cases
Number of cases
Correlation with drugs
Medication cases
Disappearance time
Incidence rate (%)
Very likely
Likely
Suspicious
Impossible
Nausea
2014
64
47
7
3
7
0
1 day~not disappear
2.83
Diarrhea
2014
15
6
5
4
0
0
1 day~2 weeks
0.74
Rash
2014
6
3
2
0
1
1
3 day~2weeks
0.25
Abdominal distension
2014
3
0
2
1
0
0
1 day~not disappear
0.15
Dry mouth
2014
2
0
0
2
0
0
1 day~not disappear
0.10
Other symptoms
2014
6
0
0
0
6
0
1 day~not disappear
0
Total
2014
96
56
16
10
14
1
4.07
Two cases of epigastric discomfort, one case of stomachache, one case of headache, one case of angina, and one case of acne. The cases correlated with drugs that were “very likely,” “likely,” and “suspicious” were used to calculate the incidence rate.
